Motor nerve hyperexcitability and muscle cramps in Machado-Joseph disease.
Kanai
Kazuaki
K
Kuwabara
Satoshi
S
D000927:Anticonvulsants / Q000009:adverse effects; D001369:Axons / Q000473:pathology; D002220:Carbamazepine / Q000009:adverse effects; D003937:Diagnosis, Differential; D018450:Disease Progression; D020439:Growth Cones / Q000502:physiology; D006801:Humans; D017827:Machado-Joseph Disease / Q000150:complications / Q000503:physiopathology*; D009046:Motor Neurons / Q000502:physiology*; D009120:Muscle Cramp / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D018482:Muscle, Skeletal / Q000294:innervation* / Q000503:physiopathology*; D009133:Muscular Atrophy / Q000209:etiology / Q000503:physiopathology; D009416:Nerve Regeneration / Q000502:physiology; D009431:Neural Conduction / Q000502:physiology; D009469:Neuromuscular Junction / Q000503:physiopathology; D009473:Neuronal Plasticity / Q000502:physiology; D010525:Peripheral Nerves / Q000503:physiopathology*; D026941:Sodium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use
D000927:Anticonvulsants; D026941:Sodium Channel Blockers; D002220:Carbamazepine